Table 1 Baseline characteristics of patients in the N group and CRT group
Characteristic | N group (N = 32) | CRT group (N = 55) | P |
|---|---|---|---|
No. (%) | No. (%) | ||
Gender | 0.886 | ||
Male | 24 (75.0%) | 42 (76.4%) | |
Female | 8 (25.0%) | 13 (23.6%) | |
Age (years) | 0.193 | ||
< 50 | 18 (56.2%) | 23 (41.8%) | |
≥ 50 | 14 (43.8%) | 32 (58.2%) | |
KPS score | 0.814 | ||
70–80 | 11 (34.4%) | 17 (30.9%) | |
90–100 | 21 (65.6%) | 38 (69.1%) | |
Histology | 0.439 | ||
Keratinizing (WHO type I) | 1 (3.1%) | 1 (1.8%) | |
Non-keratinizing differentiated (WHO type II) | 10 (31.3%) | 11 (20.0%) | |
Non-keratinizing undifferentiated (WHO type III) | 21 (65.6%) | 43 (78.2%) | |
Recurrent T classification | 0.205 | ||
T1 | 1 (3.1%) | 6 (10.9%) | |
T2 | 2 (6.3%) | 5 (9.1%) | |
T3 | 16 (50.0%) | 16 (29.1%) | |
T4 | 13 (40.6%) | 28 (50.9%) | |
Recurrent N classification | 0.557 | ||
N0 | 24 (75.0%) | 34 (61.9%) | |
N1 | 5 (15.6%) | 15 (27.3%) | |
N2 | 2 (6.3%) | 5 (9.0%) | |
N3 | 1 (3.1%) | 1 (1.8%) | |
Recurrent Clinical Stage | 0.416 | ||
I | 1 (3.1%) | 2 (3.6%) | |
II | 2 (6.2%) | 8 (14.6%) | |
III | 15 (46.9%) | 17 (30.9%) | |
IVa | 14 (43.8%) | 28 (50.9%) |